PATENT CLAIM ANALYSIS

Application Number: 15774978
Application Type: Utility
Filing Date: 2018-05
Publication Date: 2018-11
Patent Classification: ["424", "450000"]

Abstract:
Diagnostic methods for identifying cancer bearing subjects appropriate for treatment with CPX-351 include genetic and ex vivo testing of cells from a candidate subject. Combination treatment with CPX-351 and FLT-3 inhibitors improve CPX-351 uptake and toxicity.

Claim (Index 43):
The method of  claim 42  wherein the mutation is an FLT-3-ITD or FLT-3-TKD mutation.

Metadata:
- Claim Count in Document: 17.0
- Percentile: 93.0
- Lexical Diversity: 1.26667
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15715274', '14053011', '15195297', '14703500', '14212418']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7438395406678576
- 35 USC 102 Novelty (BERT): 0.5094704319460122
- Combined Prediction Score: 0.720402629795673
- Mean Citation Score: 231.841468
- Max Citation Score: 239.94547000000003
- Similarity Product: 150.73471547645633

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test